Company / Operating Cash Flow
HealthEquity Operating Cash Flow History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$242.8M
FY2026
5-year range
$105.0M / $457.1M
FY2022-FY2026
Trend
-46.9%
vs FY2025
Sector context
#78 of 164
Health Care
What the data says
At $243M, HealthEquity's operating cash flow ranks #78 of 164 in the Health Care sector. Operating Cash Flow has fluctuated over the past 10 years, ranging from $82M in FY2017 to $457M in FY2025.
Based on SEC 10-K filings.
$243M in FY2026 with a 5-year CAGR of +16.4%.
Declined from $340M to $243M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- +16.4%
- 10-Year CAGR
- -
Sector benchmark
#78 of 164 in Health CareTop 48% of 164This company $242.8M Sector average $1.0B
▼
-76.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +16.4%, indicating consistent growth.
- In FY2026, operating cash flow decreased 46.9% year-over-year.
- Ranks #78 out of 164 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2025.
Company context
Key Data Points
- Altman Z-Score 1.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $242.8M | -46.9% |
| FY2025 | $457.1M | +34.5% |
| FY2024 | $339.9M | +40.0% |
| FY2023 | $242.8M | +131.2% |
| FY2022 | $105.0M | -7.4% |
| FY2021 | $113.4M | -37.5% |
| FY2020 | $181.6M | +73.0% |
| FY2019 | $105.0M | -7.4% |
| FY2018 | $113.4M | +38.8% |
| FY2017 | $81.7M | +79.2% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026